Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma
Phase 2/3 Completed
400 enrolled 15 charts
TRABEPIO
Phase 2 Completed
10 enrolled
Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
Phase 3 Completed
138 enrolled
LEADER
Phase 1/2 Completed
30 enrolled 9 charts
TOMOREP
Phase NA Completed
48 enrolled 15 charts
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
Phase 2 Completed
57 enrolled 14 charts
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
Phase 1 Completed
32 enrolled
ANNOUNCE
Phase 3 Completed
509 enrolled 23 charts
Real-world Study of Dedifferentiated Liposarcoma Patients in China
Completed
1,390 enrolled 14 charts
Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery
Phase 2 Completed
15 enrolled 12 charts
Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas
Phase 2 Completed
29 enrolled 11 charts
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Phase 2 Completed
131 enrolled 22 charts
Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Phase 2 Completed
73 enrolled 11 charts
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery
Phase 2 Completed
164 enrolled 22 charts
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
Phase 1 Completed
16 enrolled
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Phase 2 Completed
17 enrolled
Rosiglitazone in Treating Patients With Liposarcoma
Phase 2 Completed
32 enrolled
STRASS
Phase NA Completed
266 enrolled 19 charts
SEAL
Phase 2/3 Completed
342 enrolled 36 charts
PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
Phase NA Completed
70 enrolled
Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas
Phase 2 Completed
178 enrolled 16 charts
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Phase 3 Completed
588 enrolled 22 charts
SAMHY SARCOME
Phase NA Completed
60 enrolled
TRAVELL
Phase 2 Completed
105 enrolled
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
Phase 2 Completed
54 enrolled 12 charts
Ph II Cabazitaxel DD Liposarcoma
Phase 2 Completed
42 enrolled
VORTEX
Phase 3 Completed
216 enrolled
Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma
Phase 1 Completed
74 enrolled
FILIPO
Completed
421 enrolled
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Phase 1/2 Completed
24 enrolled 14 charts
Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
Phase 2 Completed
46 enrolled 13 charts
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Phase 1/2 Completed
78 enrolled 11 charts
A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Phase 3 Completed
16 enrolled
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
Phase 2 Completed
17 enrolled 9 charts
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase 2 Completed
72 enrolled 13 charts
PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma
Phase 2 Completed
90 enrolled 7 charts
Bevacizumab and Radiation Therapy for Sarcomas
Phase 2 Completed
20 enrolled 16 charts
A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma
Phase 1 Completed
18 enrolled
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Phase 2 Completed
42 enrolled 9 charts
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Phase 2 Completed
185 enrolled
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
Phase 3 Completed
370 enrolled
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Phase 1 Completed
30 enrolled
Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
Completed
70 enrolled
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Phase 2 Completed
53 enrolled 6 charts
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
121 enrolled
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)
Phase 2 Completed
216 enrolled
Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas
Phase 1 Completed
5 enrolled
Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery
Phase 1 Completed
6 enrolled
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
Phase 3 Completed
455 enrolled